VKH
TVRD

Virtu KCG Holdings’s Tvardi Therapeutics TVRD Stock Holding History

Virtu KCG Holdings’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$772K Buy
1,393
+376
+37% +$239K 0.02% 769
2017
Q1 		$673K Buy
+1,017
New +$543K 0.02% 1064
2016
Q4 		– Sell
-824
Closed -$248K – 3864
2016
Q3 		$248K Buy
+824
New +$179K 0.01% 2145
2015
Q1 		– Sell
-280
Closed -$101K – 3986
2014
Q4 		$101K Buy
+280
New +$90.2K ﹤0.01% 3211

Other funds holding TVRD

RCP
Rho Capital Partners New York $20.4M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Virtu KCG Holdings's TVRD Position: Q2 2017 in Review

Virtu KCG Holdings increased its Tvardi Therapeutics (TVRD) stake by 37% in Q2 2017, buying an estimated $239K and bringing the position to 1,393 shares worth $772K. The position accounts for 0.02% of the portfolio, ranked #769.

Virtu KCG Holdings first reported a position in TVRD in Q4 2014 and has held it in 4 quarters since. 127 funds tracked by Wall St. Rank hold TVRD as of Q2 2017.

  • Virtu KCG Holdings held 1,393 shares of Tvardi Therapeutics worth $772K as of Q2 2017.
  • Virtu KCG Holdings bought 376 Tvardi Therapeutics shares in Q2 2017, an estimated $239K.
  • Tvardi Therapeutics made up 0.02% of Virtu KCG Holdings's portfolio in Q2 2017, its #769 holding.
  • Virtu KCG Holdings first reported a position in Tvardi Therapeutics in Q4 2014 and has held it in 4 quarters since.
  • 127 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.